Israel medical device company Memic Innovative Surgery Ltd. announced the signing of a definitive agreement for a SPAC merger with MedTech Acquisition Corporation (Nasdaq: MTAC). The merged company will have $360 million cash and an equity value of more than $1 billion.
Tadmor Levy & Co. acted as the Israeli counsel to Memic Innovative Surgery Ltd. in its agreement for a SPAC merger with MedTech Acquisition Corporation.
Memic was represented by Elie Sprung, Boaz Feinberg and Sapir Atal Davidovich.
Please click here to read the full article.